Viral hepatitis Flashcards

1
Q

Acute response of liver to hepatotropic viruses: Direct cytopathic vs immune-mediated

A

Both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Necrosis in viral hepatitis is most marked in what area

A

Centrilobular areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inflammatory infiltrates are settles in what area in cases of chronic hep

A

Inflammatory infiltrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neonates often respond to hepatic injury by forming

A

Giant cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Viral hepatitis T/F Rapidly falling aminotransferase levels reflect poor outcome

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most important marker of liver injury

A

Altered synthetic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most prevalent of the hepatotropic viruses

A

Hepatitis A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hepa viruses: Responsible for most forms of acute and benign hepatitis

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hepa viruses: RNA

A

A, C, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hepa viruses: Picornavirus

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hepa A transmission

A

Person-to-person through fecal-oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F Hepa A is responsible for ACUTE hepatitis only

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hepa A infection is diagnosed by

A

Anti-HAV IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 distinct complications of Hepa A infection

A

1) Acute liver failure, usually in adolescents and adults 2) Prolonged cholestatic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hepa A treatment

A

None specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patients infected with HAV are contagious when

A

2 weeks before and 7 days after onset of jaundice (should be excluded from school, child care, or work)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indications for IM administration of Ig and vaccine (pre- and post-exposure)

A

1) Ig for susceptible travelers to countries where HAV is endemic 2) Vaccine for healthy persons prior to travel 3) Ig for <1 y/o, patients allergic to vaccine component, or those who elect not to receive vaccine 4) Ig postexposure EXCLUSIVELY for <12 months, immunocompromised, chronic liver disease, or if vaccine is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hepa viruses: DNA

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hepa viruses: Hepadnaviridae

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hepa B: Serves as a marker of active viral replication

A

HBeAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Correlates with HBV DNA levels

A

HBeAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hepa B transmission

A

Blood transfusion and sexual contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Most important risk factor for acquisition of HBV in children

A

Perinatal exposure to an HBsAg positive mother

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T/F Breastfeeding of nonimmunized infants by infected motgers confers a greater risk of hepatitis than formula feeding

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Chronic HBV infection is defined as
Positive HBsAg for >6 months
26
T/F Risk of developing chronic HBV infection is inversely related to age of acquisition
T
27
Most prevalent cancer-related death in young adults in Asia where HBV is endemic
Hep B hepatocellular carcinoma
28
Hepa B: Direct cytopathic vs immune-mediated
Immune-mediated
29
First biochemical evidence of HBV infection
Elevation of ALT (begins to rise just before development of fatigue, anorexia, and malaise)
30
First serologic marker of infection to appear in HBV infection
HBsAg
31
HBV infection: During recovery from acute infection, ___ might be the only marker of acute infection
HBc IgM (since HBsAg levels fall before symptoms wane)
32
HBV infection: Valuable serologic marker of acute HBV infection as it rises early after the infection and remains positive for many months
Anti-HBc
33
HBV infection: Marks serologic recovery and protection
Anti-HBs
34
HBV infection: Only this serologic marker is present in persons immunized with Hep B vaccine
Anti-HBs
35
HBV infection: Marker of infectivity
HBeAg
36
T/F: HBeAg is present in active acute and chronic infection
T
37
HBV infection: Development of ___ marks improvement and is goal of therapy in chronically infected patients
Anti-HBe
38
Hepa viruses: Acute liver failure occurs more commonly with ___ than with other hepatotropic viruses
Hepa B
39
T/F Treatment of acute HBV infection is largely supportive
T
40
Goal of treatment in chronic HBV infection
Reduce viral replication
41
Reduction of viral replication in HBV infection is defined by
1) Undetectable HBV DNA in the serum 2) Development of anti-HBe
42
Hepa B: Treatment is only indicated for
Patients in immune-active form with evidence of ongoing inflammation and fibrosis, putting the child at higher risk for cirrhosis during childhood
43
Hepa B treatment: Immunomodulator with antiviral effects
IF-α-2b
44
Hepa B treatment: Oral synthetic nucleoside analog that inhibits viral enzyme reverse transcriptase
Lamivudine
45
Hepa C: Most prevalent mode of transmission
Perinatal
46
Hepa C: Direct cytopathic vs immune-mediated
Cytopathic
47
Most likely hepatotropic virus to cause chronic infection
Hepa C
48
Hepa viruses: Infection is associated with small vessel vasculitis
Hepa C
49
Hepa viruses: Infection is associated with essential mixed cryoglobulinemia
Hepa C
50
Hepa C: Most widely used serologic test
3rd generation EIA to detect anti-HCV
51
Hepa C: Most widely used virologic assay
PCR assay that detects HCV RNA
52
Hepa C: Most effective treatment in adults
Peg interferon combined with oral Ribavirin
53
Hepa C: Goal of treatment
Sustained viral response
54
Hepa C: Sustained viral response is defined as
Absence of viremia 6 months after stopping medications
55
T/F There is no vaccine available to prevent Hepa C
T
56
Annual tests done for patients in whom HCV infection is identified
1) Liver ultrasound 2) Serum AFP for HCC
57
Smallest known animal virus which is considered to be defective
Hepa D
58
Why is Hepa D considered to be defective
Cannot produce infection without concurrent HBV infection
59
T/F Concurrent infection of Hepa D with Hepa B takes 2 forms - co-infection (at the same time) or superinfection (infect a person already infected with Hepa B
T
60
Hepa D: Direct cytopathic vs immune-mediated
Cytopathic
61
HDV-HBV co-infection vs superinfection: Acute hepatitis > chronic hepatitis
Co-infection
62
HDV-HBV co-infection vs superinfection: Chronic hepatitis > acute hepatitis
Superinfection
63
HDV-HBV co-infection vs superinfection: Risk for ALF is highest
Superinfection
64
T/F HDV must be considered in all cases of acute liver failure
T
65
Diagnosis of HDV infection is made by detecting
HDV IgM
66
T/F There are no specific HDV-targeted treatments
T
67
Hepa viruses: Similar in structure to caliciviruses
HEV
68
Hepa viruses: Epidemic form was formerly called non-A, non-B hepatitis
HEV
69
HEV: Transmission
Fecal-oral
70
HEV: Direct cytopathic vs immune-mediated
Cytopathic
71
T/F Chronic illness does not occur in HEV infection
T
72
Hepa viruses: Major pathogen in pregnant women in whom it causes ALF with a high fatality incidence
HEV
73
Hepa viruses: Flavivirus
HCV, HEV, HGV
74
HAV incubation period
15-30 days
75
HBV incubation period
60-180 days
76
HCV incubation period
30-69 days
77
HEV incubation period
35-60 days
78
Hepa viruses: Causes chronic infection in 90% of patients when acquired perinatally
HBV
79
Hepa viruses: Increased risk of hepatocellular carcinoma
HBV and HCV